Sarepta Therapeutics, Inc. SRPT Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s inventories?
- Sarepta Therapeutics, Inc. (SRPT) reported inventories of $174.87M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s inventories changed year-over-year?
- Sarepta Therapeutics, Inc.'s inventories decreased by 3.5% year-over-year, from $181.16M to $174.87M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s inventories?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s inventories has grown at a -4.5% compound annual growth rate (CAGR), from $231.96M to $184.54M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.